Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Leventhal

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Transplantation|July 1, 1992
Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft modelJ R Leventhal, H C Flores, S A Gruber, et al.
Clinical Transplants|August 22, 2001
Pancreas transplantation at Northwestern UniversityD B Kaufman, J R Leventhal, M D Elliott, et al.
Transplantation Proceedings|April 1, 1996
A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipientsE M Johnson, J Zimmerman, K Duderstadt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2015
Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic BiomarkersJ R Leventhal, J M Mathew, D R Salomon, et al.
Transplantation|September 26, 2000
Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survivalJ P Fryer, J R Leventhal, W Pao, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Transplantation|July 1, 1992
Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft modelJ R Leventhal, H C Flores, S A Gruber, et al.
Clinical Transplants|August 22, 2001
Pancreas transplantation at Northwestern UniversityD B Kaufman, J R Leventhal, M D Elliott, et al.
Transplantation Proceedings|April 1, 1996
A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipientsE M Johnson, J Zimmerman, K Duderstadt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2015
Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic BiomarkersJ R Leventhal, J M Mathew, D R Salomon, et al.
Transplantation|September 26, 2000
Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survivalJ P Fryer, J R Leventhal, W Pao, et al.
Pageof 4